Skip to main content

Table 4 Conclusions generated according to different acceptance threshold ranges

From: Synthesizing evidence from clinical trials with dynamic interactive argument trees

Threshold range

Overall Conclusion

Safety Conclusion

Efficacy Conclusion

[0,0.44]

IGlar > NPH insuline

IGlar > NPH insuline

IGlar > NPH insuline

[0.45,0.70]

IGlar > NPH insuline

IGlar > NPH insuline

IGlar NPH insuline

[0.71,1]

IGlar NPH insuline

IGlar > NPH insuline

IGlar NPH insuline